Skip to content

DR. I. LEQUEU

Active Private limited companyfounded 2015active for 11 yearsHoge Buizemont 260, 9500 GeraardsbergenKBO/BCE: BE 0640.688.463

Lifetime

11 annual accounts with figures on one time axis
peak of €268,457 in 2023
€266,265▲ 0.3%
peak of €190,393 in 2023
€188,104▼ 0.5%
peak of €204,312 in 2021
€18,600▼ 62.4%
€279,818▲ 8.3%
Board1 name since 2015
1 director
Documentsfilings and deeds
25-06-202636 days before the deadline
2025micro format
Dividend €218,929Equity from €49,425 to €18,600

Key points

from the 2025 annual accounts

Equity

€18,600 from €204,312 in 2021

Equity fell by 91% in 4 years.

Debts

€279,818 94% of the balance sheet
Suppliers 1%Taxes and wages 3%Other 96%

Of this, €277,731 falls due within a year.

Filings

11 annual accounts since 2015
AprilJune31 JulyOctober201520202025

The last five annual accounts were filed 16 to 36 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,326 companies had the same profile as DR. I. LEQUEU has now. Each dot stands for 4 companies, two years later.

95.1%
were still trading
3.2%
stopped another way
1.5%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,326 companies, not a prediction for DR. I. LEQUEU. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 25-09-2015
  • 186 sharesdeed of 16-10-2015
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0640688463
changes role from manager to director “De uitoefening van de geneeskunde met specialisatie oftalmologie door de arts-aandeelhouder, met inachtneming…” (deed in Dutch) · General meeting of 25-05-2023 · Gazette deed
Registered office moved within Geraardsbergen The registered office moved from Voldersstraat 149B, 9500 Geraardsbergen to Hoge Buizemont 260, 9500 Geraardsbergen · Board meeting of 01-11-2018 · Gazette deed
Deed on capital Capital €12,400, annual accounts 2016 · Gazette deed
All 24 events

Comparable companies

same main activity, similar in size and age
Company
DR. I. LEQUEU Geraardsbergen €298,418 €266,265 6.2% -
DR. MARK DE LAAT PEDIATER Aalst €316,661 €277,446 64.3% -
Dr. Biesemans Linda, anesthesie Deinze €288,448 €246,469 67.7% -
Dr. Joke Patou Jabbeke €313,438 €274,983 17.5% -
DOCTEUR ARNAUD TOUSSAINT ORTHOPEDIE Namur €299,431 €240,622 16.6% -
Dr. Jeroen Lenz Hove €266,196 €271,380 7.0% -
Dr Patrick Maréchal Hamoir €269,111 €269,384 17.2% -

These companies have the same main activity as DR. I. LEQUEU: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €266,000 and €317,000, founded between 2014 and 2017.

Official details

Source: KBO
Status
Active since 07-10-2015Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.247.184.8459500 Geraardsbergen, since 07-10-2015
Financial year end
31 December
Peppol
Reachable since 24-11-2023
Company details

Annual accounts 2025

≈ €400,000estimated
€298,418▼ 3.0%
Filing
Filed on 25-06-2026, 36 days before the end of the filing period
Financials

Insights on DR. I. LEQUEU

DR. I. LEQUEU files the micro format. That format states no turnover. The gross margin rose from €19,709 in 2015 to €266,265 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. I. LEQUEU

What is the company number of DR. I. LEQUEU?
The company number of DR. I. LEQUEU is 0640.688.463. The VAT number is the same number with BE in front: BE 0640.688.463.
Where is DR. I. LEQUEU based?
The registered office is at Hoge Buizemont 260, 9500 Geraardsbergen.Company details
What does DR. I. LEQUEU do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. I. LEQUEU?
DR. I. LEQUEU is a private limited company (BV).
When was DR. I. LEQUEU founded?
DR. I. LEQUEU was founded on 07-10-2015.
Is DR. I. LEQUEU still active?
Yes, DR. I. LEQUEU is an active enterprise in the KBO register.
What is the turnover of DR. I. LEQUEU?
The turnover in financial year 2025 is about €400,000. This figure is estimated from the gross margin of €266,265 and 31 comparable companies (NACE 86220). It probably lies between €350,000 and €560,000.Financials
Is DR. I. LEQUEU profitable?
In financial year 2025, DR. I. LEQUEU made a profit of €188,104.
Where can I find the annual accounts of DR. I. LEQUEU?
DR. I. LEQUEU filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. I. LEQUEU due?
DR. I. LEQUEU must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.